Technical Analysis for RPRX - Royalty Pharma plc

Grade Last Price % Change Price Change
grade D 41.98 1.70% 0.70
RPRX closed up 1.7 percent on Friday, September 18, 2020, on 5.6 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical RPRX trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Upper Bollinger Band Touch Strength 0.00%
Crossed Above 20 DMA Bullish 1.70%
Pocket Pivot Bullish Swing Setup 1.70%
Multiple of Ten Bullish Other 1.70%
Outside Day Range Expansion 1.70%
MACD Bullish Signal Line Cross Bullish 3.37%
Multiple of Ten Bullish Other 3.37%
Older End-of-Day Gignals for RPRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Royalty Pharma Plc provides drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The firm's portfolio includes royalties, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta, and Vertex's Kalydeco, Symdeko and Trikafta, and four development-stage product candidates. It focuses on acquiring royalty-generating products segment. The firm invests in biopharmaceutical products. The company was founded by Pablo Gerardo Legorreta in 1996 and is headquartered in New York, NY.
Biotechnology Pharmaceutical Drug Development HIV Biopharmaceutical Products Astellas Pharma Abbvie Inc. Biopharmaceutical Industry Drug Development Services Novartis

Is RPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 56.5
52 Week Low 38.7
Average Volume 1,049,525
200-Day Moving Average 0.00
50-Day Moving Average 42.71
20-Day Moving Average 40.90
10-Day Moving Average 40.11
Average True Range 1.60
ADX 20.99
+DI 22.64
-DI 17.31
Chandelier Exit (Long, 3 ATRs ) 40.55
Chandelier Exit (Short, 3 ATRs ) 43.49
Upper Bollinger Band 43.15
Lower Bollinger Band 38.65
Percent B (%b) 0.74
BandWidth 11.00
MACD Line -0.77
MACD Signal Line -1.05
MACD Histogram 0.2823
Fundamentals Value
Market Cap 1.58 Billion
Num Shares 37.6 Million
EPS -0.62
Price-to-Earnings (P/E) Ratio -67.60
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 45.07
Resistance 3 (R3) 45.13 44.16 44.56
Resistance 2 (R2) 44.16 43.37 44.13 44.38
Resistance 1 (R1) 43.07 42.89 43.62 43.01 44.21
Pivot Point 42.10 42.10 42.37 42.07 42.10
Support 1 (S1) 41.01 41.31 41.56 40.95 39.75
Support 2 (S2) 40.04 40.83 40.01 39.58
Support 3 (S3) 38.95 40.04 39.41
Support 4 (S4) 38.89